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The antimicrobial peptide 
cathelicidin is responsible for 
ensuring sterility of urine
Many processes allow the urinary tract to remain bacteria 
free, including urine fl ow rate, rapid bladder emptying, and 
the mounting of an active infl ammatory response by white 
blood cells. Recent studies have demonstrated that many 
epithelia secrete antimicrobial peptides whose function is to 
ensure mucosal sterility. Th ese peptides belong to two families, 
defensins and cathelicidins. Defensins and cathelicidins are 
expressed in neutrophils as well. In a recent paper, Chromek et 
al. found that the urinary tracts of mice and humans produce 
the cathelicidins LL-37 and cathelin-related antimicrobial 
peptide (CRAMP). Th ese peptides (human and murine, 
respectively) are produced as longer propeptides and cleaved 
to form the active C-terminal cathelicidin. Th e proteins and 
their precursors were present in the lumen of the tubules. When 
sections of normal kidneys were exposed to uropathogenic 
Escherichia coli, the expression of cathelicidins in the tubular 
epithelial cytoplasm increased. Contact of epithelial cells 
with the bacterium resulted in its release into urine. Purifi ed 
cathelicidin killed uropathogenic E. coli in vitro. In a mouse 
model of  UTI, E. coli. were injected into the bladder, and their 
attachment to the mucosa was evaluated 1 hour later — before 
neutrophil invasion occurred. Animals defi cient in cathelicidin 
had more bacteria attached than wild-type animals. Th ey also 
had more severe signs of systemic infection, such as loss of 
weight, than wild-type animals. In addition, clinical E. coli 
strains isolated from patients with more severe urinary tract 
infections (pyelonephritis) were more resistant to cathelicidin 
killing than strains isolated from patients suff ering from cystitis. 
Th us, cathelicidin seems to be a key factor in mucosal immunity 
of the urinary tract. (Nat Med 2006; 12: 636–641)
Qais Al-Awqati
Soluble endoglin contributes to 
the pathogenesis of preeclampsia
Preeclampsia is characterized by hypertension and proteinuria 
in the third trimester of pregnancy. Th e placenta has a central 
role in preeclampsia, as evidenced by rapid disappearance of 
the disease symptoms aft er delivery. Th e clinical manifestations 
of preeclampsia refl ect widespread endothelial dysfunction, 
resulting in vasoconstriction, end-organ ischemia, and 
increased vascular permeability. Th erefore, it has long been 
suspected that a placenta-derived circulating factor(s) may 
induce the endothelial defects, leading to preeclampsia. 
Previous work has suggested that high levels of circulating 
soluble fms-like tyrosine kinase (sFlt1, also known as soluble 
VEGF receptor 1) of placental origin probably contribute to the 
pathogenesis of preeclampsia. Overexpression of sFlt1 in rats 
led to hypertension, proteinuria, and glomerular endotheliosis. 
sFlt1-treated animals, however, did not develop hemolysis 
and thrombocytopenia, complications observed in severe 
preeclampsia. A recent study by Venkatesha et al. postulates 
that other placenta-derived soluble factors may act in concert 
with sFlt1 to cause endothelial dysfunction, resulting in 
severe preeclampsia. Endoglin (Eng), or CD105, a cell surface 
coreceptor for transforming growth factor-β1 (TGF-β1) and 
TGF-β3 isoforms, is highly expressed in endothelial cells and 
syncytiotrophoblasts and modulates actions of TGF-β1 and 
TGF-β3. Th e authors found that Eng localized to caveolae, where 
it was associated with endothelial nitric oxide synthase (eNOS) 
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Immunohistochemical staining of sections from healthy human 
renal cortical tissue (a–d), a piece of human renal cortex incubated in 
cell culture medium for 24 hours (e and f), and a piece infected with 
uropathogenic E. coli for the same time (g and h). Scale bars, 50 µm (a,b 
and d); 20 µm (c,e,f,g and h).
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Renal, histological changes in pregnant rats after sEng and sFlt1 
treatment. Arrowhead: mild focal endotheliosis. Scale bars, 50 µm.
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and regulated its activity and local vascular tone, suggesting that 
Eng is involved in vascular homeostasis. Th ey also identifi ed 
a novel placenta-derived soluble TGF-β coreceptor, soluble 
endoglin (sEng), which was elevated in the sera of preeclamptic 
individuals and whose levels correlated with disease severity. 
sEng inhibited formation of capillary tubes in vitro and induced 
vascular permeability and hypertension in vivo. Its eff ects in 
pregnant rats were amplifi ed by coadministration of sFlt1 
(Figure), leading to preeclampsia and its more severe form, 
the HELLP (hemolysis, elevated liver enzymes, low platelets) 
syndrome. sEng impaired binding of TGF-β1 to its receptors and 
downstream signaling, including eff ects on activation of eNOS 
and vasodilation, suggesting that sEng leads to dysregulated 
TGF-β signaling in the vasculature. Th ese results demonstrate 
that sEng may act in concert with sFlt1 to induce severe 
preeclampsia. (Nat Med 2006; 12: 642–649)
Juan Oliver
How B cells spread and gather
B lymphocytes play an important role in the immune response to 
infection, secreting neutralizing antibodies to combat invading 
pathogens. Using sophisticated imaging and mathematical 
modeling, Batista and colleagues explain how in the early 
stages of the selection process B cells dynamically spread and 
contract over cell membranes that bear antigen (either anchored 
in the membrane or tethered to the membrane as an immune 
complex).1 A perspective by Margaret Harnett discusses this 
mechanism (Figure).2 Th is process allows the B-cell receptor to 
diff erentially sense antigens of widely varying affi  nities by the 
amount of antigen acquired, which dictates the level of B-cell 
activation. In their initial fi ndings, Batista and colleagues showed 
that B-cell receptor recognition of antigens tethered to the 
membrane led to the formation of an immunological synapse. 
By internalizing the B-cell receptor–antigen complex, 
B cells acquired antigens from target cells. Th is process enhanced 
the activation of B cells at low antigen concentration and 
affi  nity, thereby potentiating (by several orders of magnitude 
relative to soluble antigen) subsequent antigen processing and 
presentation to T cells. Th e study also showed that the integrin 
molecule LFA-1, which has been implicated in the interaction 
of B cells with follicular dendritic cells, worked with VLA-4 to 
form a region called the peripheral supramolecular activation 
cluster (pSMAC) that surrounds the central cluster of B-cell 
receptor–antigen (cSMAC). Th is suggests that B cells can form 
mature immunological synapses. Although in the initial stages 
of the immune response B cells are likely to respond in such a 
way to antigen via low-affi  nity receptors, somatic mutation in 
the germinal centers generates high-affi  nity B-cell receptors 
that are selected by competitive binding to antigen tethered 
to follicular dendritic cells in the form of immune complexes. 
Th erefore, unlike T cells that recognize antigen through low-
affi  nity interactions, B cells sense and diff erentiate a wide range 
of affi  nities in vivo. Th e gathering of antigen by B cells occurs 
without adhesion molecules or compromising the fundamental 
features of the antigen-specifi c responses. In this regard, 
Batista and colleagues clarify the powerful discriminatory 
ability of  B cells. (1Science 2006; 312: 738–741. 2Science 2006; 
312: 709–710)
Marc De Broe
B-cell discrimination of antigen affinity can dictate cell fate.
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